Genmark Diagnostics (GNMK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -42,197 | -38,263 | -33,643 | -22,103 | -23,970 |
| Depreciation Amortization | 3,870 | 3,358 | 2,844 | 1,198 | 1,326 |
| Accounts receivable | -1,983 | -2,030 | -2,390 | -2,068 | -420 |
| Accounts payable and accrued liabilities | -757 | 85 | 1,343 | 728 | 378 |
| Other Working Capital | -4,165 | -1,098 | -2,072 | 2,816 | 1,041 |
| Other Operating Activity | 13,317 | 8,376 | 10,122 | 3,186 | 2,431 |
| Operating Cash Flow | $-31,915 | $-29,572 | $-23,796 | $-16,243 | $-19,214 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 23,627 | 35,493 | -67,997 | 4,000 | -5,000 |
| PPE Investments | -3,756 | -5,726 | -4,270 | -3,476 | -1,376 |
| Purchase Sale Intangibles | -550 | -350 | -882 | -1,327 | -734 |
| Other Investing Activity | -550 | -350 | -297 | -2,670 | -734 |
| Investing Cash Flow | $19,321 | $29,417 | $-72,564 | $-2,146 | $-7,110 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 10,000 | 0 | 166 | 991 | 2,000 |
| Debt Repayment | -22 | -56 | -766 | -1,984 | -417 |
| Common Stock Issued | 1,873 | 1,343 | 86,943 | 48,523 | 34,533 |
| Other Financing Activity | -718 | 0 | -5,510 | -3,211 | -2,854 |
| Financing Cash Flow | $11,133 | $1,287 | $80,833 | $44,319 | $33,262 |
| Exchange Rate Effect | -9 | N/A | N/A | N/A | 53 |
| Beginning Cash Position | 36,855 | 35,723 | 51,250 | 25,320 | 18,329 |
| End Cash Position | 35,385 | 36,855 | 35,723 | 51,250 | 25,320 |
| Net Cash Flow | $-1,470 | $1,132 | $-15,527 | $25,930 | $6,991 |
| Free Cash Flow | |||||
| Operating Cash Flow | -31,915 | -29,572 | -23,796 | -16,243 | -19,214 |
| Capital Expenditure | -3,756 | -5,726 | -4,270 | -3,476 | -1,376 |
| Free Cash Flow | -35,671 | -35,298 | -28,066 | -19,719 | -20,590 |